NFKB1 and hepatocellular carcinoma: The activation of nuclear factor kappa B (NF-κB) is a central link between liver injury, fibrosis, and hepatocellular carcinoma (HCC) [3–5]; however, liver fibrosis and HCC may be prevented or treated by inhibiting their activation.